1. Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population.
- Author
-
Eyrich TM, Dalila N, Christoffersen M, Tybjærg-Hansen A, and Stender S
- Subjects
- Humans, Male, Female, Middle Aged, Denmark epidemiology, Aged, Heterozygote, Risk Assessment, Risk Factors, Adult, Phenotype, Biomarkers blood, Cholesterol, LDL blood, Myocardial Ischemia genetics, Myocardial Ischemia blood, Myocardial Ischemia epidemiology, Genetic Predisposition to Disease, Multifactorial Inheritance, Receptors, LDL genetics, Hyperlipoproteinemia Type II genetics, Hyperlipoproteinemia Type II blood, Hyperlipoproteinemia Type II epidemiology, Coronary Artery Disease genetics, Coronary Artery Disease blood, Coronary Artery Disease epidemiology, Apolipoprotein B-100 genetics, Apolipoprotein B-100 blood
- Abstract
Background and Aims: We tested the association of polygenic risk scores (PRS) for low-density lipoprotein cholesterol (LDL-C) and coronary artery disease (CAD) with LDL-C and risk of ischemic heart disease (IHD) in the Danish general population., Methods: We included a total of 21,485 individuals from the Copenhagen General Population Study and Copenhagen City Heart Study. For everyone, LDL-PRS and CAD-PRS were calculated, each based on >400,000 variants. We also genotyped four rare variants in LDLR or APOB known to cause familial hypercholesterolemia (FH)., Results: Heterozygous carriers of FH-causing variants in APOB or LDLR had a mean LDL-C of 5.40 and 6.09 mmol/L, respectively, and an odds ratio for IHD of 2.27 (95 % CI 1.43-3.51) when compared to non-carriers. The LDL-PRS explained 13.8 % of the total variation in LDL-C in the cohort. Individuals in the lowest and highest 1 % of LDL-PRS had a mean LDL-C of 2.49 and 4.75 mmol/L, respectively. Compared to those in the middle 20-80 %, those in the lowest and highest 1 % of LDL-PRS had odds ratios for IHD of 0.58 (95 % CI, 0.38-0.88) and 1.83 (95 % CI, 1.33-2.53). The corresponding odds ratios for CAD-PRS were 0.61 (95 % CI, 0.41-0.92) and 2.06 (95 % CI, 1.49-2.85)., Conclusions: The top 1 % of LDL-PRS and CAD-PRS conferred effects on LDL-C and risk of IHD comparable to those seen for carriers of rare FH-causing variants in APOB or LDLR. These results highlight the potential value of implementing such PRS clinically., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF